| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 |
| filingDate |
2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0997f7acb2d1ca835f009ef1336a93b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146553cb5585822f940c1d3bc53ec27f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faedd09296949dce8b11a2d3b47ac860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9febbfa6d34618d4659626f43c859bef |
| publicationDate |
2007-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2897868-A1 |
| titleOfInvention |
ANTI-IDIOTYPIC ANTIBODIES THAT NEUTRALIZE THE INHIBITORY ACTIVITY OF AN INHIBITORY ANTIBODY DIRECTED AGAINST FIELD C1 OF FACTOR VIII. |
| abstract |
The present invention relates to an anti-idiotypic monoclonal antibody directed against a factor VIII inhibitory antibody binding to the C1 domain of factor VIII, as well as to a cell line producing this anti-idiotypic monoclonal antibody, to the use of this anti-idiotypic monoclonal antibody. anti-idiotypic monoclonal antibody as a medicament, and more particularly to its use for the manufacture of a medicament for the treatment of hemophilia A. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009024653-A1 |
| priorityDate |
2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |